Sartorius Stedim Biotech, an international partner of the biopharmaceutical industry, has agreed to acquire 100 percent of Albumedix Ltd. from private investors.   The Nottingham, UK-based company provides recombinant albumin-based solutions. Recombinant human albumin is an important component for the biopharmaceutical industry required for various applications, for example as an animal-free additive to cell culture media and for the stabilization of vaccines and viral therapies.   The busin...